Search
for
Sort by
Research 601–630 of 1000+
- Diagnosis of hyperandrogenism: clinical criteria
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Hair Loss in Women
- Safety of testosterone treatment in postmenopausal women
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- PCOS in adolescents
- Dermatology of androgen-related disorders
- Approach to the adult female patient with diffuse nonscarring alopecia
- The dark art of light measurement: accurate radiometry for low-level light therapy
- Interventions for nail psoriasis
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Skin grafting for the treatment of chronic leg ulcers – a systematic review in evidence‐based medicine
- AGD1, a class 1 ARF‐GAP, acts in common signaling pathways with phosphoinositide metabolism and the actin cytoskeleton in controlling Arabidopsis root hair polarity
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Cutaneous Manifestations of Eating Disorders
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Introducing Platelet-Rich Stroma: Platelet-Rich Plasma (PRP) and Stromal Vascular Fraction (SVF) Combined for the Treatment of Androgenetic Alopecia
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Interventions for female pattern hair loss
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Prevalence of Hyperandrogenic States in Late Adolescent and Young Women: Epidemiological Survey on Italian High-School Students
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome